查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446545

药品无菌检测市场规模、份额、趋势分析报告：按类型、按产品类型、按测试类型、按样品、按最终用途、按地区、按细分市场、预测，2024-2030 年

Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (Outsourcing, In-house), By Product Type, By Test Type, By Sample, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 267 Pages | 商品交期: 2-10个工作天内

价格

药物无菌检测市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球药品无菌检测市场规模将达到32.8亿美元，2024年至2030年复合年增长率为11.02%。

全球药物上市数量的增加和政府投资的增加预计将对全球市场产生积极影响。随着製药公司将新药推向市场，对严格无菌测试通讯协定的需求也迅速增加。此外，对药品的严格监管要求进一步推动了市场成长。因此，新药上市的迅速增加为药品无菌检测市场创造了前所未有的成长机会。

此外，製药业对研发活动的日益重视正在对药品无菌检测市场产生重大影响。随着製药公司积极参与发现和开发创新和先进的配方，越来越需要强大的无菌测试通讯协定以确保这些产品的安全性和有效性。研究和开发活动需要全面的无菌测试方法，以促进新药、生技药品和疫苗的开发并符合监管要求。

此外，监管机构对药品核准的严格监管正在推动製药公司大力投资研发，以满足这些不断变化的标准。因此，市场对符合监管环境的最先进测试解决方案的需求激增。例如，2023 年 9 月，Sartorius AG 推出了用于无菌检测设备取样的 sterisart 隔垫。这是一个基于薄膜过滤方法的封闭测试系统，可降低交叉污染的风险。此类服务的推出增强了市场竞争力。

此外，製药业致力于解决未满足的医疗需求和发现创新治疗方法，进一步凸显了稳健的无菌测试通讯协定的重要性。检测潜在污染物的准确性和可靠性对于确保新上市药品的安全性和有效性至关重要。

药品无菌检测市场报告亮点

  • 按类型划分，外包细分市场以 2023 年最大的销售份额 59.25% 引领市场。该领域的成长是由无菌测试外包的需求推动的，这对于一些没有执行高品质无菌测试基础设施的中小型製药和医疗设备公司来说是一个有吸引力的选择。增加。
  • 依产品类型划分，套件和试剂细分市场领先，2023 年销售额份额最大，为 60.30%。
  • 按测试类型划分，微生物附着量测试领域在 2023 年以 41.71% 的最大销售份额引领市场。该细分市场是由对严格的品管流程和测试的需求驱动的，以量化从初始製造到最终分销的各个製造阶段产品的微生物污染。
  • 从样本来看，2023年医药部门以42.45%的最高收益占有率引领市场。本产品是一种广泛使用的剂型。全球需求的成长和这些剂型是推动这一领域的主要因素。
  • 根据最终用途，製药公司将在 2023 年占据市场主导地位。这些公司进行无菌测试以确保产品安全，特别是口服剂型。
  • 北美地区占据主导地位，2023 年销售份额为 49.45%。该地区许多主要市场参与者的存在预计将为市场成长做出重大贡献。该地区对药品和医疗设备无菌检测的严格监管要求也推动了市场成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章药品无菌检测市场：类型估计与趋势分析

  • 定义和范围
  • 细分仪表板
  • 全球药品无菌检测市场波动分析
  • 2018-2030年全球药品无菌检测市场规模及趋势分析（按类型）

第四章药品无菌检测市场：产品类型估算及趋势分析

  • 定义和范围
  • 细分仪表板
  • 全球药品无菌检测市场波动分析
  • 2018-2030年全球药品无菌检测市场规模及趋势分析（依产品类型）

第五章药品无菌检测市场：检测类型估计与趋势分析

  • 定义和范围
  • 细分仪表板
  • 全球药品无菌检测市场波动分析
  • 2018-2030 年全球药品无菌检测市场规模及趋势分析（依检测类型）

第六章药品无菌检测市场：样本估计与趋势分析

  • 定义和范围
  • 细分仪表板
  • 全球药品无菌检测市场波动分析
  • 2018-2030 年全球药品无菌检测市场规模及趋势分析（依样本）

第七章药品无菌检测市场：最终用途估计与趋势分析

  • 定义和范围
  • 细分仪表板
  • 全球药品无菌检测市场波动分析
  • 2018-2030 年全球药品无菌检测市场规模与趋势分析（依最终用途）

第八章药品无菌检测市场：区域估计和趋势分析，按类型、按产品类型、按测试类型、按样品、按最终用途

  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争形势

  • 公司分类
  • 2023 年药品无菌检测市场占有率分析
  • 主要交易及策略联盟分析
  • 供应商形势
    • Key company market share analysis, 2023
    • Pacific Biolabs
    • Steris Plc
    • Boston Analytical
    • Nelson Laboratories, LLC（Sotera Health）
    • Sartorius AG
    • SOLVIAS AG
    • SGS SA
    • Labcorp
    • Pace Analytical
    • Charles River Laboratories
    • Thermo Fisher Scientific, Inc.
    • Rapid Micro Biosystems
    • Almac Group
    • Labor LS SE &Co. KG
Product Code: GVR-2-68038-425-3

Pharmaceutical Sterility Testing Market Growth & Trends:

The global pharmaceutical sterility testing market size is anticipated to reach USD 3.28 billion by 2030 and is projected to grow at a CAGR of 11.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. A growing number of drug launches worldwide, and rising government investments are anticipated to influence the global market positively. As pharmaceutical companies are introducing an array of new drugs to the market, there is a parallel surge in the demand for rigorous sterility testing protocols. Besides, stringent regulatory requirements for pharmaceuticals products further support market growth. Thus, an upsurge in novel drug launches provided unprecedented growth opportunities to the pharmaceutical sterility testing market.

In addition, increasing emphasis on R&D activities in the pharmaceutical industry profoundly impacts the pharmaceutical sterility testing market. As pharmaceutical companies are proactively involved in the discovery and development of innovative & advanced drug formulations, there is a growing need for robust sterility testing protocols to ensure the safety and efficacy of these products. R&D activities drive the development of new pharmaceuticals, biologics, and vaccines, necessitating comprehensive sterility testing methodologies to comply with regulatory requirements.

Furthermore, stringent regulations by regulatory bodies for pharmaceutical product approval prompt pharmaceutical companies to invest significantly in R&D to meet these evolving standards. As a result, the market experiences a surge in demand for state-of-the-art testing solutions to align with the regulatory landscape. For instance, in September 2023, Sartorius AG introduced a sterisart septum for sampling from a sterility testing unit. It is a closed system for testing based on the membrane filtration method that mitigates the risk of secondary contamination. Such service launches offered a competitive edge in the market.

Moreover, the pharmaceutical industry's commitment to addressing unmet medical needs and discovering innovative therapeutic avenues further amplifies the importance of robust sterility testing protocols. The need for accuracy & reliability in detecting any potential contaminants becomes paramount to ensure the safety and efficacy of these newly launched drugs.

Pharmaceutical Sterility Testing Market Report Highlights:

  • Based on type, the outsourcing segment led the market with the largest revenue share of 59.25% in 2023. The segment growth is driven by increasing requirements for Outsourcing sterility testing as attractive alternative for several small- & medium-sized pharmaceutical and medical device companies, which may lack the infrastructure to conduct quality sterility testing
  • Based on product type, the kits and reagents segment held the market with the largest revenue share of 60.30% in 2023, attributing to a standardized and reliable techniques to determine the absence of live microorganisms in pharmaceutical products
  • Based on test type, the bioburden testing segment led the market with the largest revenue share of 41.71% in 2023. The segment is driven by strict quality control processes and the demand for testing to quantify microbial contamination of a product at different stages of production from initial manufacturing to final distribution
  • Based on sample, the pharmaceuticals segment led the market with the largest revenue share of 42.45% in 2023. The products are widely used dosage forms. The growing demand or these dosage forms globally is one of the major factors driving this segment
  • Based on end-use, the pharmaceutical companies dominated the market in 2023. These companies conduct sterility tests to ensure the safety of the products, especially oral dosage forms, as most of these products are ingested by patients
  • North America dominated the market with a revenue share of 49.45% in 2023. The presence of a large number of major market players in this region is expected to contribute to the market growth significantly. Stringent regulatory requirements for sterility testing of pharmaceuticals and medical devices in this region further supports market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details Of Primary Research
  • 1.4. Information Or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. Market Definitions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. List of Abbreviations
  • 1.11. Objectives
    • 1.11.1. Objective - 1
    • 1.11.2. Objective - 2
    • 1.11.3. Objective - 3
    • 1.11.4. Objective - 4

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot
  • 2.4. Market Lineage Outlook
    • 2.4.1. Parent Market Outlook
    • 2.4.2. Ancillary Market Outlook
  • 2.5. Pharmaceutical Sterility Testing Market Dynamics
    • 2.5.1. Market Driver Impact Analysis
      • 2.5.1.1. Supportive Government Investment In The Healthcare Industry
      • 2.5.1.2. Increasing R&D Activities
      • 2.5.1.3. Increasing Number Of Drug Launches
      • 2.5.1.4. Increasing Focus On Quality And Sterility
    • 2.5.2. Market Restraint Analysis
      • 2.5.2.1. Compliance Issues While Outsourcing
      • 2.5.2.2. Third Party Performance
  • 2.6. Pharmaceutical Sterility Testing Market: Analysis Tools
    • 2.6.1. Porter's Five Forces Analysis
    • 2.6.2. PESTEL Analysis
  • 2.7. Impact Of Covid-19 On Pharmaceutical Sterility Testing Market
  • 2.8. Post Covid-19 Reformation Strategies In The Market

Chapter 3. Pharmaceutical Sterility Testing Market: Type Estimates & Trend Analysis

  • 3.1. Definitions and Scope
    • 3.1.1. In-House
    • 3.1.2. Outsourcing
  • 3.2. Segment Dashboard
  • 3.3. Global Pharmaceutical Sterility Testing Market Movement Analysis
  • 3.4. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
    • 3.4.1. In-House
      • 3.4.1.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 3.4.2. Outsourcing
      • 3.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 4. Pharmaceutical Sterility Testing Market: Product Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Kits and Reagents
    • 4.1.2. Instruments
    • 4.1.3. Services
  • 4.2. Segment Dashboard
  • 4.3. Global Pharmaceutical Sterility Testing Market Movement Analysis
  • 4.4. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
    • 4.4.1. Kits and Reagents
      • 4.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Services
      • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Pharmaceutical Sterility Testing Market: Test Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Sterility Testing
      • 5.1.1.1. Membrane Filtration
      • 5.1.1.2. Direct Inoculation
      • 5.1.1.3. Product Flush
    • 5.1.2. Bioburden Testing
    • 5.1.3. Bacterial Endotoxin Testing
  • 5.2. Segment Dashboard
  • 5.3. Global Pharmaceutical Sterility Testing Market Movement Analysis
  • 5.4. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
    • 5.4.1. Sterility Testing
      • 5.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.2. Membrane Filtration
      • 5.4.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.3. Direct Inoculation
      • 5.4.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.4. Product Flush
      • 5.4.1.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.2. Bioburden Testing
      • 5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.3. Bacterial Endotoxin Testing
      • 5.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Pharmaceutical Sterility Testing Market: Sample Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Pharmaceuticals
    • 6.1.2. Medical Devices
    • 6.1.3. Biopharmaceuticals
  • 6.2. Segment Dashboard
  • 6.3. Global Pharmaceutical Sterility Testing Market Movement Analysis
  • 6.4. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Sample, 2018 to 2030 (USD Million)
    • 6.4.1. Pharmaceuticals
      • 6.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.2. Medical Devices
      • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.3. Biopharmaceuticals
      • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Pharmaceutical Sterility Testing Market: End-use Estimates & Trend Analysis

  • 7.1. Definitions and Scope
    • 7.1.1. Compounding Pharmacies
    • 7.1.2. Medical Device Companies
    • 7.1.3. Pharmaceutical Companies
    • 7.1.4. Others
  • 7.2. Segment Dashboard
  • 7.3. Global Pharmaceutical Sterility Testing Market Movement Analysis
  • 7.4. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
    • 7.4.1. Compounding Pharmacies
      • 7.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 7.4.2. Medical Device Companies
      • 7.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 7.4.3. Pharmaceutical Companies
      • 7.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 7.4.4. Others
      • 7.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Pharmaceutical Sterility Testing Market: Regional Estimates & Trend Analysis by Type, Product Type, Test Type, Sample, End-use

  • 8.1. Regional Market Dashboard
  • 8.2. Global Regional Market Snapshot
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.7. Netherlands
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.8. Switzerland
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Scenario
      • 8.5.8.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Scenario
      • 8.5.9.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.10. Belgium
      • 8.5.10.1. Key Country Dynamics
      • 8.5.10.2. Competitive Scenario
      • 8.5.10.3. Regulatory Scenario
      • 8.5.10.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.11. Russia
      • 8.5.11.1. Key Country Dynamics
      • 8.5.11.2. Competitive Scenario
      • 8.5.11.3. Regulatory Scenario
      • 8.5.11.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Scenario
      • 8.6.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Scenario
      • 8.6.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Scenario
      • 8.6.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.7. Philippines
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Scenario
      • 8.6.7.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.8. Malaysia
      • 8.6.8.1. Key Country Dynamics
      • 8.6.8.2. Competitive Scenario
      • 8.6.8.3. Regulatory Scenario
      • 8.6.8.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.9. New Zealand
      • 8.6.9.1. Key Country Dynamics
      • 8.6.9.2. Competitive Scenario
      • 8.6.9.3. Regulatory Scenario
      • 8.6.9.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.10. Singapore
      • 8.6.10.1. Key Country Dynamics
      • 8.6.10.2. Competitive Scenario
      • 8.6.10.3. Regulatory Scenario
      • 8.6.10.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.11. Thailand
      • 8.6.11.1. Key Country Dynamics
      • 8.6.11.2. Competitive Scenario
      • 8.6.11.3. Regulatory Scenario
      • 8.6.11.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3. Mexico
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4. Argentina
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.5. Colombia
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.6. Chile
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Scenario
      • 8.7.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Scenario
      • 8.8.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Scenario
      • 8.8.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.4. Egypt
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Scenario
      • 8.8.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.5. Israel
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Scenario
      • 8.8.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.6. UAE
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Competitive Scenario
      • 8.8.6.3. Regulatory Scenario
      • 8.8.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Pharmaceutical Sterility Testing Market Share Analysis, 2023
  • 9.3. Major Deals and Strategic Alliances Analysis
    • 9.3.1. Strategy Mapping
    • 9.3.2. Expansion
    • 9.3.3. Partnerships
    • 9.3.4. Acquisitions
  • 9.4. Vendor Landscape
    • 9.4.1. Key company market share analysis, 2023
    • 9.4.2. Pacific Biolabs
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Steris Plc
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Boston Analytical
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Nelson Laboratories, LLC (Sotera Health)
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Sartorius AG
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. SOLVIAS AG
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. SGS SA
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Labcorp
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Pace Analytical
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Charles River Laboratories
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Thermo Fisher Scientific, Inc.
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Rapid Micro Biosystems
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Almac Group
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Labor LS SE & Co. KG
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Pharmaceutical Sterility Testing market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 5 North America Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 6 North America Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 12 U.S. Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 15 Canada Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 16 Canada Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 17 Canada Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Europe Pharmaceutical Sterility Testing market, by region, 2018 - 2030 (USD Million)
  • Table 19 Europe Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 20 Europe Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 21 Europe Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 22 Europe Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 23 Europe Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 26 UK Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 27 UK Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 28 UK Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 30 Germany Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 31 Germany Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Germany Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 33 Germany Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 France Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 35 France Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 36 France Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 37 France Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 38 France Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Italy Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 40 Italy Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 41 Italy Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 42 Italy Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 43 Italy Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Spain Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Spain Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 46 Spain Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 47 Spain Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 48 Spain Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Netherlands Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 50 Netherlands Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 51 Netherlands Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 52 Netherlands Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 53 Netherlands Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Switzerland Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 55 Switzerland Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 56 Switzerland Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 57 Switzerland Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 58 Switzerland Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Sweden Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 Sweden Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 61 Sweden Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 62 Sweden Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 63 Sweden Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Belgium Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 65 Belgium Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 66 Belgium Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 67 Belgium Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 68 Belgium Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Russia Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 70 Russia Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 71 Russia Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 72 Russia Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 73 Russia Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Pharmaceutical Sterility Testing market, by region, 2018 - 2030 (USD Million)
  • Table 75 Japan Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 76 Japan Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 77 Japan Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 78 Japan Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 79 Japan Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 China Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 81 China Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 82 China Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 83 China Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 84 China Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 India Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 86 India Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 87 India Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 88 India Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 89 India Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Australia Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 91 Australia Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 92 Australia Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 93 Australia Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 94 Australia Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 South Korea Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 96 South Korea Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 97 South Korea Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 98 South Korea Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 99 South Korea Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Philippines Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 101 Philippines Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 102 Philippines Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 103 Philippines Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 104 Philippines Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 105 Malaysia Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 106 Malaysia Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 107 Malaysia Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 108 Malaysia Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 109 Malaysia Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 110 New Zealand Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 111 New Zealand Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 112 New Zealand Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 113 New Zealand Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 114 New Zealand Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 115 Singapore Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 116 Singapore Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 117 Singapore Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 118 Singapore Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 119 Singapore Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Thailand Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 121 Thailand Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 122 Thailand Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 123 Thailand Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 124 Thailand Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 125 Latin America Pharmaceutical Sterility Testing market, by region, 2018 - 2030 (USD Million)
  • Table 126 Latin America Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 127 Latin America Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 128 Latin America Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 129 Latin America Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 130 Latin America Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 131 Brazil Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 132 Brazil Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 133 Brazil Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 134 Brazil Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 135 Brazil Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 136 Mexico Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 137 Mexico Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 138 Mexico Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 139 Mexico Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 140 Mexico Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 141 Argentina Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 142 Argentina Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 143 Argentina Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 144 Argentina Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 145 Argentina Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 146 Colombia Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 147 Colombia Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 148 Colombia Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 149 Colombia Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 150 Colombia Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 151 Chile Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 152 Chile Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 153 Chile Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 154 Chile Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 155 Chile Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 156 MEA Pharmaceutical Sterility Testing market, by region, 2018 - 2030 (USD Million)
  • Table 157 MEA Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 158 MEA Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 159 MEA Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 160 MEA Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 161 MEA Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 162 South Africa Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 163 South Africa Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 164 South Africa Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 165 South Africa Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 166 South Africa Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 167 Saudi Arabia Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 168 Saudi Arabia Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 169 Saudi Arabia Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 170 Saudi Arabia Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 171 Saudi Arabia Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 172 Egypt Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 173 Egypt Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 174 Egypt Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 175 Egypt Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 176 Egypt Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 177 Israel Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 178 Israel Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 179 Israel Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 180 Israel Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 181 Israel Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 182 UAE Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 183 UAE Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 184 UAE Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 185 UAE Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 186 UAE Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Pharmaceutical sterility testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2023 (USD Million)
  • Fig. 17 Ancillary market outlook, 2023 (USD Million)
  • Fig. 18 Pharmaceutical sterility testing market dynamics
  • Fig. 19 Total R&D drug pipeline size, 2018 - 2023
  • Fig. 20 Total drug pipeline by development phase, 2023 vs. 2022
  • Fig. 21 Porter's five forces analysis
  • Fig. 22 PESTEL analysis
  • Fig. 23 Pharmaceutical sterility testing market type outlook: Segment dashboard
  • Fig. 24 Pharmaceutical sterility testing market, by type segment: Market share, 2023 & 2030
  • Fig. 25 Outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 26 In-house market, 2018 - 2030 (USD Million)
  • Fig. 27 Pharmaceutical sterility testing market product type outlook: Segment dashboard
  • Fig. 28 Pharmaceutical sterility testing market, by product type segment: Market share, 2023 & 2030
  • Fig. 29 Kits and reagents market, 2018 - 2030 (USD Million)
  • Fig. 30 Instruments market, 2018 - 2030 (USD Million)
  • Fig. 31 Services market, 2018 - 2030 (USD Million)
  • Fig. 32 Pharmaceutical sterility testing market test type outlook: Segment dashboard
  • Fig. 33 Pharmaceutical sterility testing market, by test type segment: Market share, 2023 & 2030
  • Fig. 34 Sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Membrane filtration market, 2018 - 2030 (USD Million)
  • Fig. 36 Direct inoculation market, 2018 - 2030 (USD Million)
  • Fig. 37 Product flush market, 2018 - 2030 (USD Million) Fig. 38 Bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 38 Bacterial endotoxin testing market, 2018 - 2030 (USD Million)
  • Fig. 39 Pharmaceutical sterility testing market sample outlook: Segment dashboard
  • Fig. 40 Pharmaceutical sterility testing market, by sample segment: Market share, 2023 & 2030
  • Fig. 41 Pharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 42 Medical devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Biopharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 44 Pharmaceutical sterility testing market end use outlook: Segment dashboard
  • Fig. 45 Pharmaceutical sterility testing market, by end use segment: Market share, 2023 & 2030
  • Fig. 46 Compounding pharmacies market, 2018 - 2030 (USD Million) Fig. 48 Medical devices companies market, 2018 - 2030 (USD Million)
  • Fig. 47 Pharmaceutical companies' market, 2018 - 2030 (USD Million)
  • Fig. 48 Others market, 2018 - 2030 (USD Million)
  • Fig. 49 Regional market: Key takeaways
  • Fig. 50 Regional marketplace: Key takeaways
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 North America pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 U.S. pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Canada pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 58 Europe pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 UK pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Germany pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 France pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Italy pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Spain pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Netherlands pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Switzerland pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Sweden pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Belgium pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Russia pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 79 Asia Pacific pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Japan pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 China pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 India pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Australia pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Clinical trial approval process in South Korea
  • Fig. 90 South Korea pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Singapore pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Malaysia pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Thailand pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Philippines pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 New Zealand pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 101 Latin America pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Brazil pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Mexico pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 Argentina pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Colombia pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Chile pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 112 MEA pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 South Africa pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Saudi Arabia pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 117 Key country dynamics
  • Fig. 118 Egypt pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 Israel pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 121 Key country dynamics
  • Fig. 122 Clinical trial authorization process UAE
  • Fig. 123 UAE pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 124 Market participant categorization
  • Fig. 125 Market participant categorization
  • Fig. 126 Heat map analysis